Zusammenfassung
Den zahlreichen bei Herzinsuffizienz stimulierten vasopressorischen Systemen steht als bedeutsamer endogener Gegenspieler der atriale natriuretische Faktor (ANF) gegenüber.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anderson JV, Woodruff PWR, Bloom SR (1988) The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br Heart J 59:207–211
Awazu M, Imada T, Kon V, Inagami T, Ichikawa I (1989) Role of endogenous atrial natriuretic peptide in congestive heart failure. Am J Physiol 257:R641-R646
Ballermann BJ, Brenner BM (1986) Role of atrial peptides in body fluid homeostasis. Cir Res 58:619–630
Bold AJ de, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:89–94
Dietz R, Haass M, Kübler W (1989) Atrial natriuretic factor — its possible role in hypertension and heart failure. Am J Hypertens 2:29S-33S
Dietz R, Haass M, Osterziel KJ (1991) Atrial natriuretic factor and arginine vasopressin. Lea & Febiger, Indianapolis (Progress in cardiology, vol 4/1, pp 113–133)
Espiner EA, Richards AM (1989) Atrial natriuretic peptide: an important factor in sodium and blood pressure regulation. Lancet 1:707–710
Gauer OH, Henry JP (1963) Circulatory basis of fluid volume control. Physiol Rev 43:423–481
Goetz KL (1988) Physiology and pathophysiology of atrial peptides. Am J Physiol 254:E1-E15
Goetz KL (1990) Evidence that atriopeptin is not a physiological regulator of sodium excretion. Hypertension 15:9–19
Gottlieb SS, Kukin ML, Ahern D, Packer M (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13:1534–1539
Haass M, Dietz R, Fischer ThA, Lang RE, Kübler W (1988 a) Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idopathic dilated cardiomyopathy. Am J Cardiol 62:764–770
Haass M, Dietz R, Kübler W (1988b) Hat die Plasma-ANF-Bestimmung eine diagnostische oder prognostische Bedeutung bei Patienten mit Herzvitien? Z Kardiol [Suppl 2] 77:55–60
Haass M, Fischer THA, Hänze J, Saggau W, Lang RE, Dietz R, (1990) Atrial natriuretic peptidemRNA in patients with heart disease. Am J Hypertens 3:234–236
Needleman P, Blaine EH, Greenwald JE, Michener ML, Saper CE, Stockmann PT, Tolunay HE (1989) The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol 29:23–54
Northridge DB, Jardine AG, Alabaster CT et al. (1989) Effects of UK 69578: a novel triopepti-dase inhibitor. Lancet 11:591–593
Yasue H, Obata K, Okumura K et al. (1989) Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with düated cardiomyopathy. J Clin Invest 83:46–51
Zeidel ML, Brenner BM (1987) Actions of atrial natriuretic peptide on the kidney. Semin Nephrol 7:91–97
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haass, M. (1992). Pathophysiologie — ANF-System. In: Dietz, R. (eds) Herzinsuffizienz. Aktuelle Therapieprinzipien in Kardiologie und Angiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77021-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-77021-0_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-54670-2
Online ISBN: 978-3-642-77021-0
eBook Packages: Springer Book Archive